Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation
Identifieur interne : 000E98 ( Main/Exploration ); précédent : 000E97; suivant : 000E99Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation
Auteurs : Berta Luzn-Toro ; Elena Rubio De La Torre ; Asuncin Delgado ; Jordi Prez-Tur ; Sabine Hilfiker [Espagne]Source :
- Human Molecular Genetics [ 0964-6906 ] ; 2007-09-01.
Abstract
Pathogenic mutations in the leucine-rich repeat kinase-2 (LRRK2) gene cause autosomal-dominant and certain cases of sporadic Parkinson's disease (PD). The G2019S substitution in LRRK2 is the most common genetic determinant of PD identified so far, and maps to a specific region of the kinase domain called the activation segment. Here, we show that autophosphorylation of LRRK2 is an intermolecular reaction and targets two residues within the activation segment. The prominent pathogenic G2019S mutation in LRRK2 results in altered autophosphorylation, and increased autophosphorylation and substrate phosphorylation, through a process that seems to involve reorganization of the activation segment. Our results suggest a molecular mechanistic explanation for how the G2019S mutation enhances the catalytic activity of LRRK2, thereby leading to pathogenicity. These findings have important implications for therapeutic strategies in PD.
Url:
DOI: 10.1093/hmg/ddm151
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation</title><author><name sortKey="Luzn Toro, Berta" sort="Luzn Toro, Berta" uniqKey="Luzn Toro B" first="Berta" last="Luzn-Toro">Berta Luzn-Toro</name></author><author><name sortKey="De La Torre, Elena Rubio" sort="De La Torre, Elena Rubio" uniqKey="De La Torre E" first="Elena Rubio" last="De La Torre">Elena Rubio De La Torre</name></author><author><name sortKey="Delgado, Asuncin" sort="Delgado, Asuncin" uniqKey="Delgado A" first="Asuncin" last="Delgado">Asuncin Delgado</name></author><author><name sortKey="Prez Tur, Jordi" sort="Prez Tur, Jordi" uniqKey="Prez Tur J" first="Jordi" last="Prez-Tur">Jordi Prez-Tur</name></author><author><name sortKey="Hilfiker, Sabine" sort="Hilfiker, Sabine" uniqKey="Hilfiker S" first="Sabine" last="Hilfiker">Sabine Hilfiker</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:5285C50C5E85B65CB52977E9337CFD2862CC522E</idno><date when="2007" year="2007">2007</date><idno type="doi">10.1093/hmg/ddm151</idno><idno type="url">https://api.istex.fr/document/5285C50C5E85B65CB52977E9337CFD2862CC522E/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000D85</idno><idno type="wicri:Area/Main/Curation">000C23</idno><idno type="wicri:Area/Main/Exploration">000E98</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation</title><author><name sortKey="Luzn Toro, Berta" sort="Luzn Toro, Berta" uniqKey="Luzn Toro B" first="Berta" last="Luzn-Toro">Berta Luzn-Toro</name><affiliation><wicri:noCountry code="subField">Spain and</wicri:noCountry></affiliation></author><author><name sortKey="De La Torre, Elena Rubio" sort="De La Torre, Elena Rubio" uniqKey="De La Torre E" first="Elena Rubio" last="De La Torre">Elena Rubio De La Torre</name><affiliation><wicri:noCountry code="subField">Spain and</wicri:noCountry></affiliation></author><author><name sortKey="Delgado, Asuncin" sort="Delgado, Asuncin" uniqKey="Delgado A" first="Asuncin" last="Delgado">Asuncin Delgado</name><affiliation><wicri:noCountry code="subField">Spain and</wicri:noCountry></affiliation></author><author><name sortKey="Prez Tur, Jordi" sort="Prez Tur, Jordi" uniqKey="Prez Tur J" first="Jordi" last="Prez-Tur">Jordi Prez-Tur</name><affiliation><wicri:noCountry code="syntax">???</wicri:noCountry></affiliation></author><author><name sortKey="Hilfiker, Sabine" sort="Hilfiker, Sabine" uniqKey="Hilfiker S" first="Sabine" last="Hilfiker">Sabine Hilfiker</name><affiliation><wicri:noCountry code="subField">Spain and</wicri:noCountry></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Espagne</country></affiliation></author></analytic><monogr></monogr><series><title level="j">Human Molecular Genetics</title><idno type="ISSN">0964-6906</idno><idno type="eISSN">1460-2083</idno><imprint><publisher>Oxford University Press</publisher><date type="published" when="2007-09-01">2007-09-01</date><biblScope unit="volume">16</biblScope><biblScope unit="issue">17</biblScope><biblScope unit="page" from="2031">2031</biblScope><biblScope unit="page" to="2039">2039</biblScope></imprint><idno type="ISSN">0964-6906</idno></series><idno type="istex">5285C50C5E85B65CB52977E9337CFD2862CC522E</idno><idno type="DOI">10.1093/hmg/ddm151</idno><idno type="ArticleID">ddm151</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0964-6906</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Pathogenic mutations in the leucine-rich repeat kinase-2 (LRRK2) gene cause autosomal-dominant and certain cases of sporadic Parkinson's disease (PD). The G2019S substitution in LRRK2 is the most common genetic determinant of PD identified so far, and maps to a specific region of the kinase domain called the activation segment. Here, we show that autophosphorylation of LRRK2 is an intermolecular reaction and targets two residues within the activation segment. The prominent pathogenic G2019S mutation in LRRK2 results in altered autophosphorylation, and increased autophosphorylation and substrate phosphorylation, through a process that seems to involve reorganization of the activation segment. Our results suggest a molecular mechanistic explanation for how the G2019S mutation enhances the catalytic activity of LRRK2, thereby leading to pathogenicity. These findings have important implications for therapeutic strategies in PD.</div></front></TEI><affiliations><list><country><li>Espagne</li></country></list><tree><noCountry><name sortKey="De La Torre, Elena Rubio" sort="De La Torre, Elena Rubio" uniqKey="De La Torre E" first="Elena Rubio" last="De La Torre">Elena Rubio De La Torre</name><name sortKey="Delgado, Asuncin" sort="Delgado, Asuncin" uniqKey="Delgado A" first="Asuncin" last="Delgado">Asuncin Delgado</name><name sortKey="Luzn Toro, Berta" sort="Luzn Toro, Berta" uniqKey="Luzn Toro B" first="Berta" last="Luzn-Toro">Berta Luzn-Toro</name><name sortKey="Prez Tur, Jordi" sort="Prez Tur, Jordi" uniqKey="Prez Tur J" first="Jordi" last="Prez-Tur">Jordi Prez-Tur</name></noCountry><country name="Espagne"><noRegion><name sortKey="Hilfiker, Sabine" sort="Hilfiker, Sabine" uniqKey="Hilfiker S" first="Sabine" last="Hilfiker">Sabine Hilfiker</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E98 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000E98 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:5285C50C5E85B65CB52977E9337CFD2862CC522E
|texte= Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation
}}
| This area was generated with Dilib version V0.6.23. |  |